Search

everythinglearnresearchcommunity

for

Search:↓

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Goat placenta extract in a special delivery system improved hair growth and thickness in chemotherapy patients.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

Korean Red Ginseng may protect against hair loss caused by chemotherapy.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

New treatments for hair loss are being developed using molecular biology.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

New standards were created to make chemotherapy safer and improve cancer care.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.